Ultrasound tests to spot early breast cancer treatment response
Part of Cancer, Skin clinical trials.
This study uses special ultrasound imaging (and may use MRI results) to look for early signs of how locally advanced breast cancer responds to chemotherapy, with or without radiation. If the imaging changes early, it could help doctors adjust treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer that is classified as locally advanced, confirmed by biopsy or cell sample.
- You have not started your first cancer treatment yet, and your planned treatment is chemotherapy (and possibly chemo plus radiation) before surgery.
- You have measurable disease that can be seen on ultrasound, or you had an MRI within the last 28 days.
- You are well enough to do usual activities most of the time (ECOG 0 or 1).
- You are expected to live at least 6 months and can provide written consent before any study tests.
- You do not have health or mental health problems that would make it hard to follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study looks at how well early breast cancer shrinks with treatment and how that matches with what doctors find after surgery under the microscope. The goal is to learn better ways to predict and assess treatment success.
This study uses advanced 3D ultrasound and spectroscopy to see how well breast cancer responds to chemotherapy given before surgery. It may help doctors know early if the treatment is working.
This study tests whether a special high-detail ultrasound can better show how breast cancer responds to chemotherapy given before surgery. It may help doctors tailor treatment and improve outcomes.
This trial tests whether a special ultrasound measurement can help doctors choose the right chemotherapy plan during treatment for breast cancer. It may help avoid under- or over-treatment by adjusting care based on the ultrasound results.
This study uses a special light-based imaging scan to learn more about breast masses and how tumors may respond to chemotherapy before surgery. The scan is meant to help doctors better characterize tumors and potentially track treatment response.
This study uses ultrasound to monitor a small clip placed in a lymph node affected by breast cancer to see how well it responds to chemotherapy before surgery. It might help predict if the cancer is gone from the lymph nodes without needing extra surgery.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.